Advent International to Take Nuvei Private in $6.3B Buyout
April 1, 2024
Advent International agreed to acquire Nuvei for US$34.00 per share in an all-cash transaction that values the Canadian payments company at approximately US$6.3 billion. Existing major shareholders — Philip Fayer, Novacap and CDPQ — will roll a significant portion of their equity and remain as investors, with Philip Fayer continuing as Nuvei's Chair and CEO; the deal is expected to close in late 2024 or early 2025, subject to regulatory and shareholder approvals.
- Buyers
- Advent International, Philip Fayer, Novacap, CDPQ
- Targets
- Nuvei
- Sellers
- Philip Fayer, Novacap, CDPQ, Public holders of Subordinate Voting Shares and Multiple Voting Shares (Nuvei shareholders)
- Industry
- Payments & Fintech
- Location
- Quebec, Canada
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Nuvei Acquires Paya for $1.3 Billion
January 9, 2023
Payments & Fintech
Nuvei Corporation agreed to acquire Paya Holdings Inc. in an all-cash transaction valued at approximately $1.3 billion (USD $9.75 per share). The deal combines Nuvei's global payment platform with Paya's U.S. integrated-payments and ISV capabilities to accelerate growth in eCommerce, integrated payments and B2B end markets.
-
Nuvei Acquires SafeCharge International Group Limited for US $889M
August 14, 2019
Payments & Fintech
Montreal-based payments company Nuvei, supported by private equity firm Novacap and institutional investor CDPQ, completed the acquisition of SafeCharge International Group Limited for US $889 million, privatizing the AIM-listed business. The deal combines SafeCharge's payments technology, card acquiring and risk management capabilities with Nuvei's distribution and scale, with Montreal becoming the combined organization's worldwide headquarters.
-
Advent International to Acquire Significant Stake in Suven Pharmaceuticals
December 26, 2022
Pharmaceuticals
Advent International has entered into a definitive agreement to acquire a significant stake in Suven Pharmaceuticals from the Jasti family and will make an open offer for an additional 26% of public shares. Advent plans to evaluate a merger of its CDMO and API platform company, Cohance Lifesciences, with Suven to create a scaled end-to-end CDMO + merchant API powerhouse serving pharma and specialty chemical markets, subject to board and regulatory approvals.
-
Arendals Fossekompani, Advent International and Generation Invest in Volue ASA
October 28, 2024
Software
Arendals Fossekompani, Advent International and Generation Investment Management, via their acquisition vehicle Edison Bidco, have completed a voluntary tender offer to acquire Volue ASA. The take-private buyout positions Volue to accelerate growth as a supplier of software and data solutions to the energy and infrastructure sectors, supporting both organic expansion and future add-on acquisitions.
-
Advent- and Permira-led Investor Group Acquires McAfee
November 8, 2021
Cybersecurity
An investor group led by Advent International and Permira, with Crosspoint Capital, CPP Investments, GIC and ADIA, has acquired McAfee Corp. for $26.00 per share in an all-cash take-private transaction valued at over $14 billion enterprise value. The deal, which values McAfee at roughly $12 billion equity value, will position the company to focus on expanding its consumer cybersecurity offerings with private capital and operational support.
-
Advent International and BCI Acquire Maxar Technologies
May 3, 2023
Aerospace & Defense
U.S. private equity firm Advent International, with minority investor British Columbia Investment Management Corporation (BCI), completed the acquisition of Maxar Technologies for $53.00 per share, valuing the company at approximately $6.4 billion. With the closing, Maxar is now privately held, its common stock has been de-listed from the NYSE and TSX, and the company will remain U.S.-controlled and operated.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.